These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

425 related items for PubMed ID: 18303526

  • 1. New therapies in acute decompensated heart failure.
    Gauthier N, Anselm AH, Haddad H.
    Curr Opin Cardiol; 2008 Mar; 23(2):134-40. PubMed ID: 18303526
    [Abstract] [Full Text] [Related]

  • 2. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
    Abraham WT, Adams KF, Fonarow GC, Costanzo MR, Berkowitz RL, LeJemtel TH, Cheng ML, Wynne J, ADHERE Scientific Advisory Committee and Investigators, ADHERE Study Group.
    J Am Coll Cardiol; 2005 Jul 05; 46(1):57-64. PubMed ID: 15992636
    [Abstract] [Full Text] [Related]

  • 3. The safety of intravenous diuretics alone versus diuretics plus parenteral vasoactive therapies in hospitalized patients with acutely decompensated heart failure: a propensity score and instrumental variable analysis using the Acutely Decompensated Heart Failure National Registry (ADHERE) database.
    Costanzo MR, Johannes RS, Pine M, Gupta V, Saltzberg M, Hay J, Yancy CW, Fonarow GC.
    Am Heart J; 2007 Aug 05; 154(2):267-77. PubMed ID: 17643575
    [Abstract] [Full Text] [Related]

  • 4. Overview of randomized clinical trials in acute heart failure syndromes.
    Teerlink JR.
    Am J Cardiol; 2005 Sep 19; 96(6A):59G-67G. PubMed ID: 16181824
    [Abstract] [Full Text] [Related]

  • 5. Nesiritide for heart failure: impact on costs and complications.
    Hunter CB, Ndemo F, Lenz TL, Maciejewski S, Hilleman DE.
    Expert Rev Pharmacoecon Outcomes Res; 2005 Feb 19; 5(1):15-21. PubMed ID: 19807556
    [Abstract] [Full Text] [Related]

  • 6. Comparison of dobutamine-based and milrinone-based therapy for advanced decompensated congestive heart failure: Hemodynamic efficacy, clinical outcome, and economic impact.
    Yamani MH, Haji SA, Starling RC, Kelly L, Albert N, Knack DL, Young JB.
    Am Heart J; 2001 Dec 19; 142(6):998-1002. PubMed ID: 11717603
    [Abstract] [Full Text] [Related]

  • 7. Infusion therapy in severe heart failure. A reappraisal.
    Campana C, Scelsi L, Serio A.
    Ital Heart J; 2003 May 19; 4 Suppl 2():15S-21S. PubMed ID: 14635365
    [Abstract] [Full Text] [Related]

  • 8. Standardizing care for acute decompensated heart failure in a large megatrial: the approach for the Acute Studies of Clinical Effectiveness of Nesiritide in Subjects with Decompensated Heart Failure (ASCEND-HF).
    Ezekowitz JA, Hernandez AF, Starling RC, Yancy CW, Massie B, Hill JA, Krum H, Diaz R, Ponikowski P, Metra M, Howlett JG, Gennevois D, O'Connor CM, Califf RM, Fonarow GC.
    Am Heart J; 2009 Feb 19; 157(2):219-28. PubMed ID: 19185628
    [Abstract] [Full Text] [Related]

  • 9. Contemporary in-hospital management strategies for acute decompensated heart failure.
    Sanchez CE, Richards DR.
    Cardiol Rev; 2011 Feb 19; 19(3):122-9. PubMed ID: 21464640
    [Abstract] [Full Text] [Related]

  • 10. Ultrafiltration for the management of acute decompensated heart failure.
    Wertman BM, Gura V, Schwarz ER.
    J Card Fail; 2008 Nov 19; 14(9):754-9. PubMed ID: 18995180
    [Abstract] [Full Text] [Related]

  • 11. Medical and ventilatory treatment of acute heart failure: new insights.
    Hodt A, Steine K, Atar D.
    Cardiology; 2006 Nov 19; 106(1):1-9. PubMed ID: 16582544
    [Abstract] [Full Text] [Related]

  • 12. Emerging drug therapies for the management of acute decompensated heart failure.
    Tunuguntla A.
    Tenn Med; 2007 Nov 19; 100(11):33-7. PubMed ID: 18072692
    [Abstract] [Full Text] [Related]

  • 13. Role of tolvaptan in acute decompensated heart failure.
    Ho JE, Teerlink JR.
    Expert Rev Cardiovasc Ther; 2008 Jun 19; 6(5):601-8. PubMed ID: 18510477
    [Abstract] [Full Text] [Related]

  • 14. The benefits of early vasoactive therapy in the treatment of acute decompensated heart failure.
    Albert NM.
    J Am Acad Nurse Pract; 2005 Oct 19; 17(10):403-10. PubMed ID: 16181262
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Review of current and investigational pharmacologic agents for acute heart failure syndromes.
    Shin DD, Brandimarte F, De Luca L, Sabbah HN, Fonarow GC, Filippatos G, Komajda M, Gheorghiade M.
    Am J Cardiol; 2007 Jan 22; 99(2A):4A-23A. PubMed ID: 17239703
    [Abstract] [Full Text] [Related]

  • 19. The treatment targets in acute decompensated heart failure.
    Fonarow GC.
    Rev Cardiovasc Med; 2001 Jan 22; 2 Suppl 2():S7-S12. PubMed ID: 12439356
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.